Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KXL System with VibeX for Keratoconus
NCT01972854Phase 3Terminated
- Sponsor
- Glaukos Corporation
- Start
- Nov 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of riboflavin in keratoconus, sponsored by Glaukos Corporation. Started Nov 2013; status: terminated.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT01972854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972854.